.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Federal Trade Commission
Novartis
Cipla
Accenture
Dow
Medtronic
Mallinckrodt
McKesson
Farmers Insurance

Generated: July 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084840

« Back to Dashboard
NDA 084840 describes ACETAZOLAMIDE, which is a drug marketed by Zydus Pharms Usa Inc, Alra, Heritage Pharma, Novast Labs Ltd, Lannett, Mutual Pharm, Sun Pharm Inds, Vangard, Heritage Pharms Inc, Watson Labs, Ascot, Nostrum Labs Inc, Taro, Hospira, Par Sterile Products, Sagent Agila, X Gen Pharms, West-ward Pharms Int, and Emcure Pharms Ltd, and is included in twenty NDAs. It is available from sixteen suppliers. Additional details are available on the ACETAZOLAMIDE profile page.

The generic ingredient in ACETAZOLAMIDE is acetazolamide sodium. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.

Summary for NDA: 084840

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 084840

Ingredient-typeSulfonamides
Mechanism of ActionCarbonic Anhydrase Inhibitors

Suppliers and Packaging for NDA: 084840

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACETAZOLAMIDE
acetazolamide
TABLET;ORAL 084840 ANDA Lannett Company, Inc. 0527-1050 0527-1050-01 100 TABLET in 1 BOTTLE, PLASTIC (0527-1050-01)
ACETAZOLAMIDE
acetazolamide
TABLET;ORAL 084840 ANDA Lannett Company, Inc. 0527-1050 0527-1050-05 500 TABLET in 1 BOTTLE, PLASTIC (0527-1050-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Colorcon
Cantor Fitzgerald
Deloitte
Julphar
McKinsey
Merck
Fuji
Boehringer Ingelheim
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot